Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shuku Sato

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Blood Research|February 5, 2025
Real-world effectiveness and safety of rituximab and reduced-dose CHP with polatuzumab vedotin (pola-R-CHP) in patients aged > 80 years with diffuse large B-cell lymphoma: a retrospective analysisShuku Sato, Shun Tsunoda, Wataru Kamata, et al.
Frontiers in Medicine|June 20, 2022
Case Report: A Case of Myeloproliferative Neoplasm Complicated by Alopecia AreataYotaro Tamai, Shinichi Teshima, Shun Tsunoda, et al.
Medicine|November 7, 2019
JAK2 V617F-positive essential thrombocythemia with subsequent development of immune thrombocytopenia: A case reportYasuhiro Oda, Shuku Sato, Emiko Kanbe, et al.
Journal of Clinical and Experimental Hematopathology : JCEH|June 29, 2025
Case series of long-term responders to pralatrexate in peripheral T-cell lymphomaNaoto Tomita, Koichi Kitazume, Toshiki Kitajima, et al.
Mediterranean Journal of Hematology and Infectious Diseases|November 14, 2025
Dose-Attenuated-Polatuzumab Vedotine plus CHP vs. Dose-Attenuated -R-CHOP in Patients Aged ≥ 80 Years with Diffuse Large B-Cell Lymphoma: A Retrospective, Propensity Score-Matched Analysis Stratified by Simplified Frailty ScoreShuku Sato, Emi Sawazaki, Shun Tsunoda, et al.
Internal Medicine (Tokyo, Japan)|November 3, 2017
Atraumatic Splenic Rupture Due to Ectopic Extramedullary Hematopoiesis after Autologous Stem Cell Transplantation in a Patient with AL AmyloidosisShuku Sato, Yotaro Tamai, Satomi Okada, et al.
Internal Medicine (Tokyo, Japan)|August 5, 2014
Hemophagocytic lymphohistiocytosis secondary to Mycoplasma pneumoniae infection without pneumoniaMakoto Hibino, Shuku Sato, Takanori Shimizu, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 26, 2015
[Unidentified Inflammatory Disease Induced by Azacitidine Therapy for Myelodysplastic Syndrome]Shunichiro Inagaki, Yotaro Tamai, Masaki Yoshizawa, et al.
International Journal of Hematology|March 9, 2025
Retrospective analysis of treatment discontinuation in minimal residual disease negative multiple myelomaShuku Sato, Emi Sawazaki, Shun Tsunoda, et al.
Internal Medicine (Tokyo, Japan)|June 8, 2018
Invasive Pulmonary Aspergillosis in the Epidural Space in a Patient with Acute Myelogenous Leukemia with Myelodysplasia-related Changes: A Case Study and Literature Review of Vertebral Aspergillosis in JapanRyohei Ono, Shuku Sato, Satomi Okada, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Blood Research|February 5, 2025
Real-world effectiveness and safety of rituximab and reduced-dose CHP with polatuzumab vedotin (pola-R-CHP) in patients aged > 80 years with diffuse large B-cell lymphoma: a retrospective analysisShuku Sato, Shun Tsunoda, Wataru Kamata, et al.
Frontiers in Medicine|June 20, 2022
Case Report: A Case of Myeloproliferative Neoplasm Complicated by Alopecia AreataYotaro Tamai, Shinichi Teshima, Shun Tsunoda, et al.
Medicine|November 7, 2019
JAK2 V617F-positive essential thrombocythemia with subsequent development of immune thrombocytopenia: A case reportYasuhiro Oda, Shuku Sato, Emiko Kanbe, et al.
Journal of Clinical and Experimental Hematopathology : JCEH|June 29, 2025
Case series of long-term responders to pralatrexate in peripheral T-cell lymphomaNaoto Tomita, Koichi Kitazume, Toshiki Kitajima, et al.
Mediterranean Journal of Hematology and Infectious Diseases|November 14, 2025
Dose-Attenuated-Polatuzumab Vedotine plus CHP vs. Dose-Attenuated -R-CHOP in Patients Aged ≥ 80 Years with Diffuse Large B-Cell Lymphoma: A Retrospective, Propensity Score-Matched Analysis Stratified by Simplified Frailty ScoreShuku Sato, Emi Sawazaki, Shun Tsunoda, et al.
Internal Medicine (Tokyo, Japan)|November 3, 2017
Atraumatic Splenic Rupture Due to Ectopic Extramedullary Hematopoiesis after Autologous Stem Cell Transplantation in a Patient with AL AmyloidosisShuku Sato, Yotaro Tamai, Satomi Okada, et al.
Internal Medicine (Tokyo, Japan)|August 5, 2014
Hemophagocytic lymphohistiocytosis secondary to Mycoplasma pneumoniae infection without pneumoniaMakoto Hibino, Shuku Sato, Takanori Shimizu, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 26, 2015
[Unidentified Inflammatory Disease Induced by Azacitidine Therapy for Myelodysplastic Syndrome]Shunichiro Inagaki, Yotaro Tamai, Masaki Yoshizawa, et al.
International Journal of Hematology|March 9, 2025
Retrospective analysis of treatment discontinuation in minimal residual disease negative multiple myelomaShuku Sato, Emi Sawazaki, Shun Tsunoda, et al.
Internal Medicine (Tokyo, Japan)|June 8, 2018
Invasive Pulmonary Aspergillosis in the Epidural Space in a Patient with Acute Myelogenous Leukemia with Myelodysplasia-related Changes: A Case Study and Literature Review of Vertebral Aspergillosis in JapanRyohei Ono, Shuku Sato, Satomi Okada, et al.
Pageof 4